WashU Medicine – Pulmonary Nodules and Early Stage Lung Cancer 2026 – November 6, 2026
Revolutionize your pulmonary diagnostic and thoracic care capabilities! Dive into a high-yield, 7-hour immersive symposium featuring hands-on procedural labs in liquid biomarkers, ultrathin bronchoscopy, cryobiopsy, robotic navigation, and bronchoscopic ablation. Empower your interprofessional team to streamline early detection, optimize non-surgical and surgical treatment plans, and claim up to 7 AMA PRA Category 1 Credits™!
Held at The Ritz-Carlton, St. Louis 100 Carondelet Plaza, St. Louis, Missouri, USA, 63105
Cost: $125-$250
View Offer chevron_rightKey Features
- Format & Duration: A live, 1-day (7-hour) course featuring lectures, interactive sessions, and hands-on labs.
- Multidisciplinary & Collaborative Focus: Meticulously planned by physicians, nurses, and respiratory therapists to foster a team-based approach to lung nodule and early-stage lung cancer care.
- For Physicians: Covers Electromagnetic Navigation Radial Endobronchial Ultrasound, Ultrathin Bronchoscopy, Robotic Bronchoscopy, and Cryobiopsy.
- For Nurses, Nurse Practitioners, & Respiratory Therapists: Focuses on bronchoscopy room setup, preparation, procedural aspects, recovery, and simulated procedures.
Topics Covered
- Screening guidelines and biopsy timing
- Advanced diagnostic technologies (liquid biomarkers, ultrathin bronchoscopy, robotic bronchoscopy)
- Treatment innovations (bronchoscopic ablation, novel navigational techniques)
- Surgical and non-surgical treatment strategies for early-stage lung cancer
Learning Objectives
At the conclusion of this activity, learners will be able to:
- Integrate evidencebased diagnostic protocols and novel therapeutic interventions into routine clinical workflows.
- Evaluate surgical, radiologic, and systemic treatment options to formulate tailored management plans for patients with earlystage lung cancer.
- Identify and apply advanced diagnostic modalities for the early detection and risk stratification of pulmonary nodules.
Target Audience
Pulmonary physicians, interventional pulmonologists, cardiothoracic surgeons, medical oncologists, radiation oncologists, nurses, respiratory therapists, physician associates, and other healthcare professionals involved in lung cancer care.
Additional credit info
Pulmonary physicians, interventional pulmonologists, cardiothoracic surgeons, medical oncologists, radiation oncologists, nurses, respiratory therapists, physician associates, and other healthcare professionals involved in lung cancer care.